Tick-Borne Disease Prevention Protocol

A Preventable Threat That Still Catches Owners Off Guard

Tick-borne diseases are among the most preventable serious health threats dogs face — and among the most common ones that still slip through. Lyme disease nephritis can cause irreversible kidney failure. Chronic ehrlichiosis can drive immune-mediated destruction of platelets and bone marrow suppression that persists years beyond initial treatment. Rocky Mountain spotted fever carries high acute mortality in untreated dogs. In high-risk regions of the northeastern United States, CAPC surveillance data shows Lyme seroprevalence rates exceeding 10%.

Tick prevention is one component of a broader parasite prevention strategy that also addresses fleas, heartworm, and intestinal parasites. The products to prevent these diseases exist and work well. The problem is how they are used. Studies consistently show that tick preventive application is seasonal, intermittent, or based on perceived exposure rather than systematic annual coverage. In regions where Ixodes ticks are active from early spring through late fall — a window that keeps expanding with warming temperatures — month-by-month coverage gaps create cumulative exposure risk over a dog’s lifetime.

What the Evidence Shows About Prevention

• Isoxazoline oral preventives (fluralaner, afoxolaner, sarolaner) achieve tick mortality within 8-12 hours of attachment — critical because Borrelia transmission requires 24-36 hours of attachment; faster-killing products are preferred for Lyme prevention.
• Ixodes scapularis (black-legged tick, deer tick) is the primary Lyme disease vector in the northeastern and upper Midwestern US. Dermacentor variabilis (American dog tick) is the primary Rocky Mountain spotted fever vector across most of the US.
• Lyme vaccination adds a meaningful additional layer of protection in high-risk regions: the OspC-based vaccines (Nobivac Lyme, Recombitek Lyme) reduce Lyme seroconversion risk by approximately 70-80% when used alongside consistent preventive.
• Year-round versus seasonal tick prevention in endemic areas: dogs on year-round coverage had Lyme seroprevalence rates approximately 4x lower than dogs on seasonal coverage in a multi-year northeastern US field study.
• Tick attachment time matters: ticks that are physically removed within 24 hours of attachment transmit Borrelia at very low rates; ticks attached for 48+ hours have substantially higher transmission efficiency.
• Concurrent Anaplasma phagocytophilum infection is common with Lyme disease — ehrlichia and anaplasmosis diagnostic panels should be run alongside Lyme 4Dx testing annually in endemic areas.

Building a Year-Round Prevention Protocol

Build a systematic year-round tick prevention protocol calibrated to geographic risk.

• Assess geographic tick risk: use CAPC’s parasite prevalence maps (capcvet.org) to determine which tick species and tick-borne diseases are prevalent in your area. Risk is not uniform across the US.
• Select a product class: isoxazoline orals (Bravecto, NexGard, Simparica) are currently the highest-evidence class for rapid tick mortality, particularly for Lyme prevention. Topical permethrin collars (Seresto) provide 8-month duration and are effective for owners who cannot reliably administer monthly orals.
• In endemic Lyme regions (northeastern US, upper Midwest, Pacific coastal areas): add Lyme vaccination as a complementary layer. Vaccinate and booster per label schedule before tick season.
• Administer tick preventive every 1-3 months (per product label) year-round in endemic regions; do not apply only during perceived “tick season” — the active window is expanding.
• Perform a thorough tick check after each outdoor activity in brushy or wooded areas: check ears, between toes, groin, axilla, and around the collar. Promptly remove attached ticks with fine-tipped tweezers.
• Run annual SNAP 4Dx (Lyme + ehrlichia + anaplasma + heartworm) screening regardless of tick product use — seroconversion detection enables early treatment before chronic disease establishes.
• For dogs that have seroconverted to Lyme: run quantitative C6 antibody titer and urine protein:creatinine ratio to assess Lyme nephritis risk before disease progresses.

Tracking and Annual Screening

Tick-borne disease prevention is monitored through annual serology, preventive adherence tracking, and physical tick checks.

• Annual SNAP 4Dx or equivalent: screens for Lyme, ehrlichia, and anaplasma simultaneously; positive results require confirmatory testing and treatment decision.
• Preventive administration log: note each dose administered with date — this identifies accidental coverage gaps that may not be apparent from memory alone.
• Urine protein:creatinine ratio annually in dogs seropositive for Lyme: detects early subclinical Lyme nephritis before creatinine rises.
• Physical tick check after every outdoor high-exposure activity: ticks removed within 24 hours rarely transmit Lyme disease.

Four Mistakes That Leave Dogs Exposed

• Stopping tick prevention in winter because “ticks are dormant” — in many US regions, black-legged ticks are active whenever temperatures exceed 40°F; January and February gaps create real exposure windows.
• Relying on tick checking alone without preventive — tick checks miss many ticks, particularly nymphal ticks (poppy-seed sized) that are the primary Lyme vectors.
• Treating Lyme as a local concern only in the Northeast — Lyme geographic range has expanded significantly; current CAPC maps show increasing seroprevalence in the Midwest, Southeast, and Pacific coast.
• Not adding Lyme vaccination because the dog is on preventive — vaccines and preventives work through different mechanisms and provide additive protection in high-risk areas.

Frequently Asked Questions

Which tick preventive is best for Lyme prevention specifically?

Isoxazoline oral products (fluralaner/Bravecto, afoxolaner/NexGard, sarolaner/Simparica) kill ticks within 8-12 hours of attachment, well within the 24-36 hour window required for Borrelia transmission. Their speed of kill makes them the preferred class for Lyme-endemic areas. Seresto collar provides comparable sustained protection with 8-month duration.

Is Lyme vaccination worth it for my dog?

In high-risk areas (northeastern US, upper Midwest), yes. Vaccines provide approximately 70-80% risk reduction for seroconversion when used alongside preventive. The risk of Lyme nephritis — irreversible kidney failure — makes additional protection meaningful. AAHA guidelines include Lyme vaccine as a lifestyle-based recommendation in endemic regions.

Can dogs with positive Lyme titers be treated successfully?

Most Lyme-seropositive dogs never develop clinical disease. Dogs with clinical Lyme disease (lameness, fever, lymphadenopathy) respond well to doxycycline (4 weeks). Lyme nephritis is the serious complication — early detection through UPC ratio monitoring is key, as it progresses to renal failure if not caught.

Do tick preventives also cover other tick-borne diseases beyond Lyme?

Yes, but with varying efficacy. Most isoxazolines reduce tick attachment and feeding across species; since many tick-borne diseases (ehrlichiosis from Amblyomma, RMSF from Dermacentor) transmit more rapidly than Lyme disease, the kill-speed advantage of isoxazolines still provides meaningful protection across pathogens.

Bottom Line

Year-round tick prevention with an isoxazoline oral or Seresto collar, combined with annual 4Dx screening and Lyme vaccination in endemic areas, provides the highest achievable protection against tick-borne disease in companion dogs. Consistent parasite prevention is increasingly recognized as a meaningful longevity lever — not just a comfort measure.

References

• Littman MP et al. ACVIM consensus update on Lyme borreliosis in dogs and cats. J Vet Intern Med. 2018.
• Bowman D et al. Prevalence and geographic distribution of Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilum in dogs in the United States. Vet Parasitol. 2009.
• CAPC (Companion Animal Parasite Council). Parasite prevalence maps. capcvet.org. 2024.